Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
Airway Therapeutics has raised $24.0M in total funding. The most recent round was Series E. The last funding was announced in August 2026.
Airway Therapeutics's investors include CincyTech, Cincinnati Children’s, QCA Ventures, KTECH Capital, Danmar Capital.
Airway Therapeutics is headquartered in Marietta, United States.
Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
Airway Therapeutics is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Airway Therapeutics — Funding & Investors." VCBacked, August 25, 2026, https://www.vcbacked.co/company/airway-therapeutics. Accessed September 15, 2026.
VCBacked. (2026). Airway Therapeutics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/airway-therapeutics
{{cite web |title=Airway Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/airway-therapeutics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated